11β-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects
The DOI matches its Crossref record; 321 of the 322 references it cites were found in a registry or an index.
Abstract
11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) interconverts the inactive glucocorticoid cortisone and its active form cortisol. It is widely expressed and, although bidirectional, in vivo it functions predominantly as an oxoreductase, generating active glucocorticoid. This allows glucocorticoid receptor activation to be regulated at a prereceptor level in a tissue-specific manner. In this review, we will discuss the enzymology and molecular biology of 11β-HSD1 and the molecular basis of cortisone reductase deficiencies. We will also address how altered 11β-HSD1 activity has been implicated in a number of disease states, and we will explore its role in the physiology and pathologies of different tissues. Finally, we will address the current status of selective 11β-HSD1 inhibitors that are in development and being tested in phase II trials for patients with the metabolic syndrome. Although the data are preliminary, therapeutic inhibition of 11β-HSD1 is also an exciting prospect for the treatment of a variety of other disorders such as osteoporosis, glaucoma, intracranial hypertension, and cognitive decline.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These trials have more or less uniformly demonstrated a benefit, with lifestyle more efficacious than all medications with the exception of the thiazolidinediones140–152.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [140]
In the citing paper
“Interestingly, activation/inactivation of glucocorticoids and 11-oxygenated androgens work in an antiparallel manner, with the 11β-hydroxy derivative being the active glucocorticoid [74,75], while the 11-keto androgens are more potent than their 11β-hydroxy counterparts [76].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [74]
In the citing paper
“subsequently occurs in peripheral mineralocorticoid target tissue, such as the kidney, the colon and the salivary glands all of which express HSD11B2 [74].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [74]
In the citing paper
“Cortisone is in-turn reactivated to cortisol by the action of HSD11B1 expressed predominantly in the liver, as well as some peripheral tissues such as adipose tissue, muscle, skin and bone [74,[232], [233], [234], [235]].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [74]
In the citing paper
“which cannot activate the glucocorticoid receptor or the MR”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [74]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
The Neuroendocrinology of Stress and Aging: The Glucocorticoid Cascade Hypothesis
Sapolsky, R. M., Krey, L. C., & McEwen, B. S. (2002) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2002.38.cp21 · Cited by 2,299
The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis
SAPOLSKY, R. M., KREY, L. C., & McEWEN, B. S. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-3-284 · Cited by 2,298
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.
Cao, Z., Umek, R. M., & McKnight, S. L. (1991) · Genes & Development · doi:10.1101/gad.5.9.1538 · Cited by 1,663
Gould, E., Tanapat, P., McEwen, B. S., Flügge, G., & Fuchs, E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3168 · Cited by 1,395
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Wellcome Trust Case Control Consortium, & The Australo-Anglo-American Spondylitis Consortium (TASC) (2007) · Nature Genetics · doi:10.1038/ng.2007.17 · Cited by 1,374
Research works printed but not linked: 2
- Kendell, 1971, Cortisone: Memoirs of a hormone hunter, 121
- Tiganescu, 2011, 11 β-Hydroxysteroid dehydrogenase type 1 increases with age and photoexposure in human skin ex vivo, J Invest Dermatol, 131, S91
Cited by
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1137 · Cited by 2,043
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Self-citationCauses, consequences, and treatment of metabolically unhealthy fat distribution
Stefan, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30110-8 · Cited by 541
Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450
“active glucocorticoid [74,75], while the 11-keto androgens are more potent than their 11β-hydroxy counterparts [76].”
Early-life stress, HPA axis adaptation, and mechanisms contributing to later health outcomes
Maniam, J., Antoniadis, C., & Morris, M. J. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00073 · Cited by 295
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
Self-citationIntracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“HSD11B1 plays an important role in the recycling of cortisol from its inactive metabolite cortisone (Gathercole et al., 2013) and might therefore also be involved in the hepatic metabolism of 11-oxygenated androgens.”
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. W. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 209
Self-citationKaserer, T., Beck, K., Akram, M., Odermatt, A., & Schuster, D. (2015) · Molecules · doi:10.3390/molecules201219880 · Cited by 207
Non-alcoholic fatty liver disease in lean individuals
Albhaisi, S., Chowdhury, A., & Sanyal, A. J. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.08.002 · Cited by 174
Glucocorticoids and non-alcoholic fatty liver disease
Woods, C. P., Hazlehurst, J. M., & Tomlinson, J. W. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.020 · Cited by 171
Self-citationCole, T. J., Short, K. L., & Hooper, S. B. (2019) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2019.05.005 · Cited by 164
Minireview: New Molecular Mediators of Glucocorticoid Receptor Activity in Metabolic Tissues
Patel, R., Williams-Dautovich, J., & Cummins, C. L. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1062 · Cited by 108
Stefan, N., Ramsauer, M., Jordan, P., Nowotny, B., Kantartzis, K., Machann, J., Hwang, J., Nowotny, P., KAHL, S., Harreiter, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70170-0 · Cited by 120
Self-citationPrevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions
Jun, L., Robinson, M., Geetha, T., Broderick, T. L., & Babu, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032973 · Cited by 115
Lengton, R., Schoenmakers, M., Penninx, B. W. J. H., Boon, M. R., & van Rossum, E. F. C. (2024) · Clinical Obesity · doi:10.1111/cob.12725 · Cited by 107
11-Ketotestosterone Is a Major Androgen Produced in Human Gonads
Imamichi, Y., Yuhki, K.-I., Orisaka, M., Kitano, T., Mukai, K., Ushikubi, F., Taniguchi, T., Umezawa, A., Miyamoto, K., & Yazawa, T. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2311 · Cited by 96
Medicinal Chemistry of Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
Scott, J. S., Goldberg, F. W., & Turnbull, A. V. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4014746 · Cited by 99
Ghosh, R. K., Ball, S., Prasad, V., & Gupta, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.063 · Cited by 98
Mazziotti, G., Formenti, A. M., Frara, S., Roca, E., Mortini, P., Berruti, A., & Giustina, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0154 · Cited by 96
Gut microbiota, hypertension and chronic kidney disease: Recent advances
Sircana, A., Michieli, F. D., Parente, R., Framarin, L., Leone, N., Berrutti, M., Paschetta, E., Bongiovanni, D., & Musso, G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.013 · Cited by 96
Cortisol excess in chronic kidney disease – A review of changes and impact on mortality
Sagmeister, M. S., Harper, L., & Hardy, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1075809 · Cited by 93
11β-hydroxysteroid dehydrogenases: A growing multi-tasking family
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111210 · Cited by 89
Gender-Specific Differences in Skeletal Muscle 11β-HSD1 Expression Across Healthy Aging
Hassan-Smith, Z. K., Morgan, S. A., Sherlock, M., Hughes, B., Taylor, A. E., Lavery, G. G., Tomlinson, J. W., & Stewart, P. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1516 · Cited by 77
Self-citationIdiopathic intracranial hypertension: a step change in understanding the disease mechanisms
Yiangou, A., Mollan, S. P., & Sinclair, A. J. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00893-0 · Cited by 86
Self-citationSevilla, L. M., Jiménez‐Panizo, A., Alegre‐Martí, A., Estébanez‐Perpiñá, E., Caelles, C., & Pérez, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810049 · Cited by 85
Markey, K. A., Mitchell, J., Botfield, H. F., Ottridge, R. S., Matthews, T., Krishnan, A., Woolley, R. L., Westgate, C. S. J., Yiangou, A., Alimajstorovic, Z., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcz050 · Cited by 79
Self-citationZeng, Z., Huang, S., & Sun, T. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00922-x · Cited by 78
Steroid secretion in healthy aging
Fiacco, S., Walther, A., & Ehlert, U. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.035 · Cited by 78
Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterations
Alcubierre, D. D., Ferrari, D., Mauro, G. C. D., Isidori, A. M., Tomlinson, J., & Pofi, R. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02091-7 · Cited by 78
Self-citationCognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
Grech, O., Clouter, A., Mitchell, J., Alimajstorovic, Z., Ottridge, R. S., Yiangou, A., Roque, M., Tahrani, A. A., Nicholls, M., TAYLOR, A. E. R., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab202 · Cited by 76
Self-citationGlucocorticoid therapy and ocular hypertension
Dibas, A., & Yorio, T. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.018 · Cited by 75
Esche, J., Shi, L., Sánchez‐Guijo, A., Hartmann, M. F., Wudy, S. A., & Remer, T. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.033 · Cited by 69
11β-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story
Odermatt, A., & Klusoňová, P. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.08.011 · Cited by 59
Woods, C. P., Corrigan, M., Gathercole, L., TAYLOR, A. E. R., Hughes, B. A., Gaoatswe, G., Manolopoulos, K. N., Hogan, A. E., O’Connell, J., Stewart, P. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4120 · Cited by 55
Self-citationBrent, M. B. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108383 · Cited by 54
Rao, R. T., & Androulakis, I. P. (2017) · Endocrinology · doi:10.1210/en.2017-00544 · Cited by 49
Glucocorticoids, bone and energy metabolism
Cooper, M. S., Seibel, M. J., & Zhou, H. (2015) · Bone · doi:10.1016/j.bone.2015.05.038 · Cited by 53
Self-citationGregory, S., Hill, D., Grey, B., Ketelbey, W., Miller, T., Muniz-Terrera, G., & Ritchie, C. W. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154246 · Cited by 45
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Othonos, N., Pofi, R., Arvaniti, A., White, S. J., Bonaventura, I., Nikolaou, N., Moolla, A., Marjot, T., Stimson, R. H., van Beek, A. P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36541-w · Cited by 50
Self-citationVariation in glucocorticoid sensitivity and the relation with obesity
Lengton, R., Iyer, A. M., van der Valk, E. S., Hoogeveen, E. K., Meijer, O. C., van der Voorn, B., & van Rossum, E. F. C. (2021) · Obesity Reviews · doi:10.1111/obr.13401 · Cited by 50
Accessing biological actions of Ganoderma secondary metabolites by in silico profiling
Grienke, U., Kaserer, T., Pfluger, F., Mair, C. E., Langer, T., Schuster, D., & Rollinger, J. M. (2014) · Phytochemistry · doi:10.1016/j.phytochem.2014.10.010 · Cited by 45
Emerging role of GIP and related gut hormones in fertility and PCOS
Moffett, R. C., & Naughton, V. R. (2020) · Peptides · doi:10.1016/j.peptides.2019.170233 · Cited by 44
Shah, N. Z., Abdalla, M. A., Deshmukh, H., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211042145 · Cited by 44
Virtual screening applications in short-chain dehydrogenase/reductase research
Beck, K. R., Kaserer, T., Schuster, D., & Odermatt, A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.008 · Cited by 40
Oda, S., Ashida, K., Uchiyama, M., Sakamoto, S., Hasuzawa, N., Nagayama, A., Wang, L., Nagata, H., Sakamoto, R., Kishimoto, J., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab450 · Cited by 40
Melis, D., Rossi, A., Pivonello, R., Salerno, M., Balivo, F., Spadarella, S., Muscogiuri, G., Casa, R. D., Formisano, P., Andria, G., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0301-2 · Cited by 39
Alterations of Cortisol Metabolism in Human Disorders
White, P. C. (2018) · Hormone Research in Paediatrics · doi:10.1159/000485508 · Cited by 39
Webster, J. M., Fenton, C. G., LANGEN, R. C. J., & Hardy, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225768 · Cited by 38
Melo, L. M. N., Herrera-Rios, D., Hinze, D., Löffek, S., Ozel, I., Turiello, R., Klein, J., Leonardelli, S., Westedt, I. V., Al-Matary, Y. S., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004150 · Cited by 38
Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension
Westgate, C. S. J., Markey, K. A., Mitchell, J., Yiangou, A., Singhal, R., Stewart, P. M., Tomlinson, J., Lavery, G. G., Mollan, S. P., & Sinclair, A. J. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0108 · Cited by 36
Self-citationThe Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 35
Lee, S., Kim, S., Choi, I., Song, Y., Kim, N., Ryu, H. C., Lim, J. W., Kang, H. J., Kim, J., & Seo, H. R. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05452-x · Cited by 35
Sarafoglou, K., Merke, D. P., Reisch, N., der Grinten, H. L. C., Falhammar, H., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad134 · Cited by 35
Lutz, S. Z., Peter, A., Machicao, F., Lamprinou, A., Machann, J., Schick, F., Königsrainer, I., Königsrainer, A., Fritsche, A., Staiger, H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2498 · Cited by 27
Formation of Threohydrobupropion from Bupropion Is Dependent on 11β-Hydroxysteroid Dehydrogenase 1
Meyer, A., Vuorinen, A., Zielinska, A. E., Strajhar, P., Lavery, G. G., Schuster, D., & Odermatt, A. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052936 · Cited by 34
Self-citationNovel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient
Rochester, C. D., & Akiyode, O. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i3.305 · Cited by 34
Siggelkow, H., Etmanski, M., Bozkurt, S., Groβ, P., Koepp, R., Brockmöller, J., & Tzvetkov, M. V. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1418 · Cited by 29
Hammer, F., Deutschbein, T., Marx, A., Güder, G., Michalski, R., Ertl, G., Allolio, B., Angermann, C. E., Störk, S., & Faßnacht, M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.084 · Cited by 32
Sarafoglou, K., Zimmerman, C. L., Gonzalez‐Bolanos, M. T., Willis, B. A., & Brundage, R. C. (2015) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000121 · Cited by 32
Al‐Kofahi, M., AHMED, M. A., Jaber, M. M., Tran, T. N., Willis, B. A., Zimmerman, C. L., Gonzalez‐Bolanos, M. T., Brundage, R. C., & Sarafoglou, K. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14470 · Cited by 31
The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat
Pierce, J. L., Ding, K.-H., Xu, J., Sharma, A. K., Yu, K., del Mazo Arbona, N., Rodríguez-Santos, Z., Bernard, P. J., Bollag, W. B., Johnson, M. H., et al. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0230 · Cited by 30
Loerz, C., & Maser, E. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.07.030 · Cited by 30
Taves, M. D., Plumb, A. W., Korol, A. M., van der Gugten, J. G., Holmes, D. T., Abraham, N. B., & Soma, K. K. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.05.003 · Cited by 30
YADAV, Y. R., Dunagan, K. T., Khot, R., Venkatesh, S. K., Port, J. D., Galderisi, A., Cobelli, C., Wegner, C. D., Basu, A., Carter, R. E., et al. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14646 · Cited by 29
Ajjan, R., Elizabeth, H., Shams, K., Galdo, F. D., Abbas, A., Woods, J., Fairclough, R. J., Webber, L., Pegg, L., Freeman, A., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1197 · Cited by 29
Self-citationCurrent Understanding of the Pathophysiology of Idiopathic Intracranial Hypertension
Lowe, M., Berman, G., Sumithran, P., & Mollan, S. P. (2025) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-025-01420-y · Cited by 28
Cortisol metabolism, postnatal depression and weight changes in the first 12 months postpartum
Rogers, S. L., Hughes, B. A., Tomlinson, J., & Blissett, J. M. (2016) · Clinical Endocrinology · doi:10.1111/cen.13150 · Cited by 28
Self-citationAge- and gender-related changes in glucose homeostasis in glucocorticoid-treated rats
dos Santos, C., Ferreira, F. B. D., Gonçalves-Neto, L. M., Taboga, S. R., Boschero, A. C., & Rafacho, A. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0259 · Cited by 27
Jain, I., Brougham-Cook, A., & Underhill, G. H. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.06.018 · Cited by 26
Crowley, R. K., Hughes, B., Gray, J., McCarthy, T., Hughes, S., Shackleton, C. H. L., Crabtree, N., Nightingale, P., Stewart, P. M., & Tomlinson, J. W. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0256 · Cited by 26
Self-citationTargeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity
Zhong, C., Li, N., Wang, S., Li, D., Yang, Z., Du, L., Huang, G., Li, H., Yeung, W. S., He, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52965-4 · Cited by 26
Li, J., Kennedy, L. J., Wang, H., Li, J. J., Walker, S. J., Hong, Z., O’Connor, S. P., Nayeem, A., Camac, D. M., Morin, P. E., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500144h · Cited by 25
Quantitative Profiling of Cortisol Metabolites in Human Urine by High-Resolution Accurate-Mass Ms
Wang, Y., Fujioka, N., & Xing, C. (2018) · Bioanalysis · doi:10.4155/bio-2018-0182 · Cited by 25
Webster, J. M., Sagmeister, M. S., Fenton, C. G., Seabright, A. P., Lai, Y., Jones, S. W., Filer, A. D., Cooper, M. S., Lavery, G. G., Raza, K., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157828 · Cited by 24
Self-citationLarner, D. P., Morgan, S., Gathercole, L., Doig, C. L., Guest, P., Weston, C. J., Hazeldine, J., Tomlinson, J., Stewart, P. M., & Lavery, G. G. (2016) · Endocrinology · doi:10.1210/en.2016-1357 · Cited by 24
Self-citationGlycometabolic Alterations in Secondary Adrenal Insufficiency: Does Replacement Therapy Play a Role?
Graziadio, C., Hasenmajer, V., Venneri, M. A., Gianfrilli, D., Isidori, A. M., & Sbardella, E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00434 · Cited by 24
Hu, M., Zhang, Y., Guo, X., Jia, W., Liu, G., Zhang, J., Cui, P., Li, J., Li, W., Wu, X., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116681 · Cited by 23
Ye, X., Chen, S., Wu, S. C., Yoon, D. S., Wang, H., Hong, Z., O’Connor, S. P., Li, J., Li, J. J., Kennedy, L. J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00211 · Cited by 22
Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines
Uslar, T., Newman, A. J., Tapia-Castillo, A., Carvajal, C. A., Fardella, C., Allende, F. A., Solari, S., Tsai, L. C., Milks, J., Cherney, M. D., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae663 · Cited by 21
Li, H., Hu, S., Wu, R., Zhou, H., Zhang, K., Li, K., Lin, W., Shi, Q., Chen, H., & Lv, S. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82933 · Cited by 21
The mineralocorticoid receptor in skin disease
Pérez, P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15736 · Cited by 21
Panigrahi, S. K., Toedesbusch, C. D., McLeland, J., Lucey, B. P., & Wardlaw, S. L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz274 · Cited by 20
Woods, C. P., & Tomlinson, J. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-2895-8_16 · Cited by 20
Self-citationBlaschke, M., Koepp, R., Streit, F., Beismann, J., Manthey, G., Seitz, M., Kragl, A., & Siggelkow, H. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105850 · Cited by 19
Learning pharmacokinetic models for in vivo glucocorticoid activation
Bunte, K., Smith, D. J., Chappell, M. J., Hassan-Smith, Z. K., Tomlinson, J., Arlt, W., & Tiňo, P. (2018) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2018.07.025 · Cited by 19
Self-citationSchiffer, L., Oestlund, I., Snoep, J. L., Gilligan, L. C., TAYLOR, A. E. R., Sinclair, A. J., Singhal, R., Freeman, A., Ajjan, R., Tiganescu, A., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302131r · Cited by 18
Self-citationAnimal Models of Cushing's Syndrome
Nishiyama, M., Iwasaki, Y., & Makino, S. (2022) · Endocrinology · doi:10.1210/endocr/bqac173 · Cited by 18
11β-HSD1 Inhibition Rescues SAMP8 Cognitive Impairment Induced by Metabolic Stress
Puigoriol‐Illamola, D., Leiva, R., Vázquez‐Carrera, M., Vázquez, S., Griñán‐Ferré, C., & Pallàs, M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01708-4 · Cited by 18
Lagos, C. F., Vecchiola, A., Allende, F. A., Fuentes, C., Tichauer, J. E., Valdivia, C. P., Solari, S., Campino, C., Tapia-Castillo, A., Baudrand, R. F., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.01.011 · Cited by 18
Schluessel, S., Zhang, W., Nowotny, H. F., Bidlingmaier, M., Hintze, S., Kunz, S. L., Martini, S., Mehaffey, S., Meinke, P., Neuerburg, C., et al. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02574-w · Cited by 16
Hall, L., & Hart, R. (2023) · International Journal of Dermatology · doi:10.1111/ijd.16967 · Cited by 16
Effect of Experimental Kidney Disease on the Functional Expression of Hepatic Reductases
Alshogran, O. Y., Naud, J., Ocque, A. J., Leblond, F. A., Pichette, V., & Nolin, T. D. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061150 · Cited by 16
Regulation of bone mass in endocrine diseases including diabetes
Higham, C., & Abrahamsen, B. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101614 · Cited by 15
On the Intimate Relationship of Adiposity to Polycystic Ovary Syndrome
Rosenfield, R. L., & Dumesic, D. A. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf527 · Cited by 15
Glucocorticoid metabolism in rheumatoid arthritis
Hardy, R., Raza, K., & Cooper, M. S. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12389 · Cited by 15
Self-citationPenno, C. A., Morgan, S., Vuorinen, A., Schuster, D., Lavery, G. G., & Odermatt, A. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m042499 · Cited by 15
Self-citationCho, J., Lee, Y., Starost, M. F., Mansfield, B. C., & CHOU, J. Y. (2019) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12056 · Cited by 16
Morris, D. J., Brem, A. S., & Odermatt, A. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105988 · Cited by 14
Metadata
- Authors
- Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- ORCID
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2013-08-01
- Volume
- 34
- Issue
- 4
- Pages
- 525-555
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2146575585
- Cited by
- 196
- References
- 322
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 11 · 2023: 25 · 2022: 10 · 2021: 14 · 2020: 7 · 2019: 15 · 2018: 13 · 2017: 19 · 2016: 14 · 2015: 13 · 2014: 21 · 2013: 6
- FWCI
- 2.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NIHR-CS-011-028, CL-2009-09-001, NF-SI-0508-10356)
- Medical Research Council (MR/K015184/1)
- Biotechnology and Biological Sciences Research Council (BB/G023468/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, glucocorticoid metabolism, cortisone, cortisol, glucocorticoid receptor, 11β-HSD1 inhibitors, metabolic syndrome, osteoporosis, glaucoma, intracranial hypertension, cognitive decline
- MeSH terms
- Animals, Endocrine System Diseases, Endocrine Glands, Enzyme Inhibitors, Humans, Genetic Variation, Drugs, Investigational, Metabolic Syndrome, 11-beta-Hydroxysteroid Dehydrogenase Type 1, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.